214 related articles for article (PubMed ID: 29398593)
1. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
3. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
[TBL] [Abstract][Full Text] [Related]
4. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
5. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
6. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer.
Bhatnagar A; Loper A
Radiat Oncol; 2010 Sep; 5():87. PubMed ID: 20875139
[TBL] [Abstract][Full Text] [Related]
7. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.
Guix B; Finestres F; Tello J; Palma C; Martinez A; Guix J; Guix R
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):95-102. PubMed ID: 10758310
[TBL] [Abstract][Full Text] [Related]
8. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy.
Park SY; Kang S; Park JM; An HJ; Oh DH; Kim JI
Brachytherapy; 2019; 18(2):224-232. PubMed ID: 30528742
[TBL] [Abstract][Full Text] [Related]
9. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.
Bhatnagar A
Brachytherapy; 2013; 12(2):134-40. PubMed ID: 23312675
[TBL] [Abstract][Full Text] [Related]
10. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly.
Roberson J; Patel R; Slutsky JB; Ryu S; Xu Z; Valentine E
Brachytherapy; 2021; 20(4):818-827. PubMed ID: 33789824
[TBL] [Abstract][Full Text] [Related]
11. Optimized penile surface mold brachytherapy using latest stereolithography techniques: A single-institution experience.
D'Alimonte L; Ravi A; Helou J; Morrison D; Mendez LC; Easton H; Morton G
Brachytherapy; 2019; 18(3):348-352. PubMed ID: 30718175
[TBL] [Abstract][Full Text] [Related]
12. High dose rate brachytherapy with customized applicators for malignant facial skin lesions.
Jumeau R; Renard-Oldrini S; Courrech F; Buchheit I; Oldrini G; Vogin G; Peiffert D
Cancer Radiother; 2016 Jul; 20(5):341-6. PubMed ID: 27321412
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
[TBL] [Abstract][Full Text] [Related]
14. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
15. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
17. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
[TBL] [Abstract][Full Text] [Related]
18. Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy.
Kellas-Ślęczka S; Białas B; Fijałkowski M; Wojcieszek P; Szlag M; Cholewka A; Wesołowski M; Ślęczka M; Krzysztofiak T; Larysz D; Kołosza Z; Trzaska K; Pruefer A
Brachytherapy; 2019; 18(4):493-502. PubMed ID: 31101437
[TBL] [Abstract][Full Text] [Related]
19. Optimizing surface mould brachytherapy for treatment of nasal basal cell carcinoma using customized applicators.
Barnes EA; Tsao MN; Taggar AS; Ravi A; Paudel MR
Brachytherapy; 2023; 22(5):665-672. PubMed ID: 37277286
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.
Gabani P; Cyr AE; Zoberi JE; Ochoa LL; Matesa MA; Thomas MA; Garcia J; Margenthaler JA; Naughton MJ; Ma C; Sanati S; Zoberi I
Brachytherapy; 2018; 17(1):171-180. PubMed ID: 29089275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]